News
If you've been hopping between arms for booster shots, a new study suggests that your lymph nodes remember exactly where you ...
a leading provider of fit-for-purpose antibody discovery services, announced today that for the first time, single plasma B-cell discovery services will be part of the company’s exclusive ...
Antibodies are secreted immunoglobulin molecules produced mainly by plasma cells. The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly ...
Researchers uncover corneal changes in multiple myeloma patients treated with belantamab mafodotin, revealing potential ...
According to Towards Healthcare research, the global polyclonal antibodies market size is calculated at USD 1.76 billion in ...
Spinal cord pain isn't always just muscle strain — it could signal multiple myeloma. Learn the critical symptoms you must not ...
Regeneron’s bispecific antibody linvoseltamab, now branded as Lynozyfic, has received conditional approval from the European ...
12d
Pharmaceutical Technology on MSNEC conditionally approves Regeneron’s Lynozyfic for multiple myelomaThe EC has granted conditional marketing approval to Regeneron Pharmaceuticals’ bispecific antibody Lynozyfic for treating ...
Multiple myeloma can arise when plasma cells transform into malignant plasma cells which leads to the uncontrolled growth of these abnormal plasma cells.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results